Bispecific Targeting of EGFR and uPAR in a Mouse Model of Head and Neck Squamous Cell Carcinoma

Por Waldron, Nate N., Oh, Seunguk, Vallera, Daniel
Publicado em 2012

A bispecific EpCAM/CD133 targeted toxin is effective against carcinoma

Por Waldron, Nate N., Barsky, Sanford H., Vallera, Daniel A.
Publicado em 2013

Victory and Defeat in the Induction of a Therapeutic Response through Vaccine Therapy for Human and Canine Brain Tumors: A Review of the State of the Art

Por Olin, Michael R., Pluhar, G. Elizabeth, Andersen, Brian M., Shaver, Rob, Waldron, Nate N., Moertel, Christopher L.
Publicado no Crit Rev Immunol (2014)

Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer

Por Waldron, Nate N., Kaufman, Dan S., Oh, Seunguk, Inde, Zintis, Hexum, Melinda K., Ohlfest, John R., Vallera, Daniel A
Publicado em 2011

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression

Por Skubitz, Amy P.N., Taras, Elizabeth P., Boylan, Kristin L.M., Waldron, Nate N., Oh, Seunguk, Panoskaltsis-Mortari, Angela, Vallera, Daniel A.
Publicado em 2013

Identification and characterization of a novel scFv recognizing human and mouse CD133

Por Swaminathan, Suresh Kumar, Niu, Lin, Waldron, Nate, Kalscheuer, Steve, Zellmer, David M., Olin, Michael R., Ohlfest, John R., Vallera, Daniel A., Panyam, Jayanth
Publicado no Drug Deliv Transl Res (2013)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy

Por Moertel, Christopher L, Xia, Junzhe, LaRue, Rebecca, Waldron, Nate N, Andersen, Brian M, Prins, Robert M, Okada, Hideho, Donson, Andrew M, Foreman, Nicholas K, Hunt, Matthew A, Pennell, Christopher A, Olin, Michael R
Publicado no J Immunother Cancer (2014)